CRL-1337

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCRL-1337
Drug Alias NameCRL-1337
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnticancer multidrug resistance inhibitors
TargetsUpdating
Therapy Area/IndicationsBreast NeoplasmsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCytrx Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCytrx Corp
Active IndicationsN/A
Inactive IndicationsBreast NeoplasmsLeukemia

Other Information

ATC CodeN/A
Related LinksN/A